Envoy Medical (NASDAQ:COCH) Price Target Raised to $8.75 at Ascendiant Capital Markets

Envoy Medical (NASDAQ:COCH) had its price target increased by Ascendiant Capital Markets from $8.50 to $8.75 in a research report report published on Tuesday, Benzinga reports. Ascendiant Capital Markets currently has a buy rating on the stock.

Envoy Medical Stock Performance

Shares of COCH stock opened at $3.33 on Tuesday. The business has a fifty day moving average of $2.47 and a 200 day moving average of $3.48. Envoy Medical has a 1 year low of $0.75 and a 1 year high of $11.72.

Envoy Medical (NASDAQ:COCH) last issued its earnings results on Monday, August 12th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.24) by ($0.03). The company had revenue of $0.07 million during the quarter, compared to the consensus estimate of $0.08 million. Equities research analysts anticipate that Envoy Medical will post -1.36 EPS for the current year.

Hedge Funds Weigh In On Envoy Medical

Institutional investors have recently modified their holdings of the stock. WealthTrust Asset Management LLC purchased a new position in shares of Envoy Medical during the 1st quarter valued at about $44,000. Virtu Financial LLC purchased a new position in shares of Envoy Medical during the 1st quarter valued at about $55,000. Finally, Weiss Asset Management LP purchased a new position in shares of Envoy Medical during the 4th quarter valued at about $37,000. Hedge funds and other institutional investors own 8.59% of the company’s stock.

Envoy Medical Company Profile

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.